BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21788602)

  • 1. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.
    Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB
    Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
    Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
    JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
    Fleg JL; Mete M; Howard BV; Umans JG; Roman MJ; Ratner RE; Silverman A; Galloway JM; Henderson JA; Weir MR; Wilson C; Stylianou M; Howard WJ
    J Am Coll Cardiol; 2008 Dec; 52(25):2198-205. PubMed ID: 19095139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
    Wilson C; Huang CC; Shara N; Howard BV; Fleg JL; Henderson JA; Howard WJ; Huentelman H; Lee ET; Mete M; Russell M; Galloway JM; Silverman A; Stylianou M; Umans J; Weir MR; Yeh F; Ratner RE
    J Clin Lipidol; 2010; 4(3):165-72. PubMed ID: 20563294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.
    Mete M; Wilson C; Lee ET; Silverman A; Russell M; Stylianou M; Umans JG; Wang W; Howard WJ; Ratner RE; Howard BV; Fleg JL
    J Diabetes Complications; 2011; 25(6):362-7. PubMed ID: 21775166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
    Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
    Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study.
    Ludwig M; Stapff M; Ribeiro A; Fritschka E; Tholl U; Smith RD; Stumpe KO
    Clin Ther; 2002 Jul; 24(7):1175-93. PubMed ID: 12182261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.
    Russell M; Silverman A; Fleg JL; Lee ET; Mete M; Weir M; Wilson C; Yeh F; Howard BV; Howard WM
    J Clin Lipidol; 2010; 4(5):435-43. PubMed ID: 21076630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
    Weir MR; Yeh F; Silverman A; Devereux RB; Galloway JM; Henderson JA; Howard WJ; Russell M; Wilson C; Ratner R; Sorkin J; Umans JG; Fleg JL; Stylianou M; Lee E; Howard BV
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):540-8. PubMed ID: 19817934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased arterial stiffness in familial combined hyperlipidemia.
    Brouwers MC; Reesink KD; van Greevenbroek MM; Meinders JM; van der Kallen CJ; Schaper N; Hoeks AP; Stehouwer CD
    J Hypertens; 2009 May; 27(5):1009-16. PubMed ID: 19402225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
    Zheng L; Hodis HN; Buchanan TA; Li Y; Mack WJ
    Am J Cardiol; 2007 Apr; 99(7):956-60. PubMed ID: 17398191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population.
    Eguchi K; Schwartz JE; Roman MJ; Devereux RB; Gerin W; Pickering TG
    J Clin Hypertens (Greenwich); 2007 May; 9(5):337-44. PubMed ID: 17485969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet.
    Lee YJ; Choi DH; Kim EJ; Kim HY; Kwon TO; Kang DG; Lee HS
    Am J Chin Med; 2011; 39(1):39-52. PubMed ID: 21213397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D; Malmqvist K; Held C; Kahan T
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
    Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
    Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
    Karpov RS; Koshel'skaia OA; Khoroshilova IV
    Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.
    Lee JM; Robson MD; Yu LM; Shirodaria CC; Cunnington C; Kylintireas I; Digby JE; Bannister T; Handa A; Wiesmann F; Durrington PN; Channon KM; Neubauer S; Choudhury RP
    J Am Coll Cardiol; 2009 Nov; 54(19):1787-94. PubMed ID: 19874992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.